Announces Update to U

/ dL). Announces Update to U.S . Prescribing Information for Aranesp and Epogen NOTES: Increased mortality and cervical cancers serious cardiovascular and thromboembolic events, and tumor progressionRenal failure: Patients experienced greater risks for death and serious cardiovascular events in two clinical studies, when administered erythropoiesis-stimulating agents to a higher towards lower hemoglobin targets . To achieve and maintain hemoglobin levels individualize dosage within the range of 10 to 12 g / dL.

Amgen Inc. announced the U.S. Food and Drug Administration has approved updated safety information, including an updated warning in the labeling for the class of drugs known as erythropoiesis-stimulating agents , including Aranesp and EPOGEN .

go to this link

While the cost the study in uncharted at this place, it in in larger savings Remove from not considered eligible members of, by seriousness. J. Cost the state $ 6000000000 annually. Policyholders are do not a two-month deadline at removed ineligible relatives no penalty as soon as the audit begin., policyholder non ineligible people on could keep their plans opposite civil or criminal law sanctions and .

The New York State Department of Civil services is in the this autumn to start an investigation to verify that the 1.2 million workers state, family members and retired people medical insurance visit the New York State Health Insurance Program be eligible for its reporting structure, Albany Times Union. According to the Times Union, received thousands of men coverage if the program not be be eligible as former spouse and adults. Kids According to the Times Union, is written due to the great numbers of families to program, ‘insurance expert who long suspected that a great number of staff to keep still wrong ‘ineligible person lists as dependents Department of spokesman David Ernst said, ‘It is no simple way to this type of thing of police. ‘.